^
    CANCER:

    Thymoma

    Contact us to learn more about our Premium Content:
    News alerts, weekly reports and conference planners
    Related cancers:
    No biomarker
    Thymoma
    GEM-CAP
    Sensitive
    :
    A2
    No biomarker
    Thymoma
    LV5FU2
    Sensitive
    :
    A2
    No biomarker
    Thymoma
    CaT
    Sensitive
    :
    A2
    No biomarker
    Thymoma
    VIP
    Sensitive
    :
    A2
    No biomarker
    Thymoma
    CAP
    Sensitive
    :
    A2
    No biomarker
    Thymoma
    etoposide IV
    Sensitive
    :
    A2
    No biomarker
    Thymoma
    ifosfamide
    Sensitive
    :
    A2
    No biomarker
    Thymoma
    CAP + prednisone
    Sensitive
    :
    A2
    No biomarker
    Thymoma
    ADOC
    Sensitive
    :
    A2
    No biomarker
    Thymoma
    EP
    Sensitive
    :
    A2
    No biomarker
    Thymoma
    carboplatin
    Sensitive
    :
    A2
    No biomarker
    Thymoma
    pembrolizumab
    Resistant
    :
    A2
    No biomarker
    Thymoma
    gemcitabine
    Sensitive
    :
    A2
    No biomarker
    Thymoma
    paclitaxel
    Sensitive
    :
    A2
    No biomarker
    Thymoma
    pemetrexed
    Sensitive
    :
    A2
    No biomarker
    Thymoma
    prednisone + octreotide
    Sensitive
    :
    A2
    No biomarker
    Thymoma
    octreotide
    Sensitive
    :
    A2
    No biomarker
    Thymoma
    everolimus
    Sensitive
    :
    A2
    IGF1R expression
    Thymoma
    everolimus
    Resistant
    :
    C3
    EIF4EBP1 expression
    Thymoma
    everolimus
    Resistant
    :
    C3
    PD-L1 overexpression
    Thymoma
    pembrolizumab
    Sensitive
    :
    C4